Select Medical (NYSE:SEM) Issues FY24 Earnings Guidance

Select Medical (NYSE:SEMGet Free Report) updated its FY24 earnings guidance on Thursday. The company provided earnings per share guidance of $1.96-2.20 for the period, compared to the consensus earnings per share estimate of $2.12. The company issued revenue guidance of $6.9-7.1 billion, compared to the consensus revenue estimate of $7.01 billion. Select Medical also updated its FY 2024 guidance to 1.960-2.200 EPS.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on the stock. Benchmark restated a buy rating and set a $48.00 price target on shares of Select Medical in a research report on Friday. Royal Bank of Canada boosted their target price on shares of Select Medical from $36.00 to $40.00 and gave the company an outperform rating in a report on Monday, May 6th. Two research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of Moderate Buy and a consensus target price of $36.50.

View Our Latest Report on SEM

Select Medical Trading Down 12.8 %

Shares of Select Medical stock traded down $5.00 on Friday, reaching $34.18. The company had a trading volume of 2,367,259 shares, compared to its average volume of 708,812. The firm’s 50 day moving average price is $35.77 and its two-hundred day moving average price is $31.13. The firm has a market cap of $4.44 billion, a PE ratio of 16.28, a PEG ratio of 1.78 and a beta of 1.43. Select Medical has a 52-week low of $21.28 and a 52-week high of $40.50. The company has a debt-to-equity ratio of 2.30, a quick ratio of 1.22 and a current ratio of 1.22.

Select Medical (NYSE:SEMGet Free Report) last announced its earnings results on Thursday, August 1st. The health services provider reported $0.60 earnings per share for the quarter, topping the consensus estimate of $0.59 by $0.01. Select Medical had a net margin of 3.91% and a return on equity of 17.88%. The firm had revenue of $1.76 billion for the quarter, compared to the consensus estimate of $1.74 billion. During the same period in the prior year, the firm earned $0.61 EPS. The firm’s revenue for the quarter was up 5.1% on a year-over-year basis. Sell-side analysts predict that Select Medical will post 2.19 earnings per share for the current fiscal year.

Select Medical Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, August 30th. Investors of record on Wednesday, August 14th will be paid a dividend of $0.125 per share. This represents a $0.50 annualized dividend and a yield of 1.46%. The ex-dividend date of this dividend is Wednesday, August 14th. Select Medical’s payout ratio is currently 23.81%.

Select Medical Company Profile

(Get Free Report)

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.

Further Reading

Earnings History and Estimates for Select Medical (NYSE:SEM)

Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.